Both low and moderate-high intensity exercise could help fight against Alzheimer's
- In March and April 2025, the National Institutes of Health halted federal funding for some Alzheimer's disease research centers and grants.
- These funding cuts resulted from a Trump administration review and restructuring of the Department of Health and Human Services.
- Approximately a dozen centers await renewal decisions, while others like UC Davis had multiyear grants abruptly terminated.
- In March, the NIH halted funding for 14 of 35 centers; democratic lawmakers stated the administration stopped $65 million.
- These funding uncertainties could delay development of new treatments and affect patients currently receiving trial medications.
16 Articles
16 Articles
Purple canoe completes mission in Hanalei
LIHUE — Mayor Derek S.K. Kawakami joined Cindy Fowler of the Alzheimer’s Association and caregiver Denise Robinson on Wednesday to congratulate Wendy Norcross and Frank Wattunen of Ely, Minnesota, for completing the couple’s mission of paddling in all 50 states to honor Wendy’s parents, both of whom died from dementia. “This inspiring journey is part of ‘The Longest Day,’ an Alzheimer’s Association initiative that encourages people to turn their…
Both low and moderate-high intensity exercise could help fight against Alzheimer's
Researchers at University of California San Diego and Wake Forest University have found that both low and moderate-high intensity exercise could be valuable tools in the fight against Alzheimer's.
Uncertainty around NIH funding leaves Alzheimer’s studies in limbo
(CNN) — Zahydie Burgos Ribot and her husband, Francisco Rios, are checking items off their travel bucket list and spending quality time together before Francisco will no longer be able to travel – and before his brain forgets.
Clinical trials to test vaccine against Alzheimer's-promoting tau protein
Researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau after demonstrating that this vaccine generated a robust immune response in both mice and non-human primates.
Clinical trials are the next step for testing vaccine against Alzheimer's-promoting tau protein
University of New Mexico Health Sciences researchers hope to launch human clinical trials in their quest for a vaccine to prevent the buildup of pathological tau—a protein in the brain associated with Alzheimer's dementia.
Low and Moderate Exercise May Help Prevent Alzheimer’s Decline
New findings from the EXERT study reveal that both low and moderate-high intensity exercise may help preserve cognitive function in older adults with mild memory problems, a major risk factor for Alzheimer’s disease. Over 12 months, participants who engaged in either form of exercise showed significantly less cognitive decline and reduced brain volume loss, especially in the prefrontal cortex, compared to a usual-care group.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage